Life science and biotech industry expert.
Pekka Simula (born 1974) is a board member of Sartar Therapeutics. Mr. Simula has hold previously many life science and bioindustry expert positions: such as Project Director at CRF Health, Global Program Manager at Varian Medical Systems, CEO of Herantis Pharma and a founding CEO of Oncos Therapeutics, until the company’s merger with Norwegian Targovax in 2015. Mr. Simula is also a Chairman of the Board of the Finnish Bioindustries and Chairman of the Health & Wellbeing Advisory Board of Business Finland.
